Alison M. Mcdonnell
15 Hospital Ave
Nedlands, WA 6009, Australia
Nedlands, WA 6009, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patients.
Journal: Oxford open immunology
Published: December 10, 2024
Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade.
Journal: Journal for immunotherapy of cancer
Published: September 08, 2024
Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy.
Journal: Cell reports. Medicine
Published: December 26, 2023
Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management.
Journal: Frontiers in immunology
Published: September 20, 2022
Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations.
Journal: Frontiers in immunology
Published: February 09, 2022
Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells.
Journal: Burns & trauma
Published: October 05, 2021
IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies.
Journal: Frontiers in immunology
Published: July 02, 2021
Malignant Pleural Effusions-A Window Into Local Anti-Tumor T Cell Immunity?
Journal: Frontiers in oncology
Published: February 26, 2021
A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers.
Journal: Expert review of anticancer therapy
Published: January 29, 2021
Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors.
Journal: Scientific reports
Published: December 10, 2020
Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy.
Journal: Frontiers in immunology
Published: July 17, 2020
Last Updated: 09/26/2026